Skip to content

Epic™ Vascular H74939200081220Recalls & reported problems

Boston Scientific Corporation · Self-Expanding Stent System · Class 3

All models of Epic Vascular (50)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08714729805588), received between Aug 6, 2018 and Jun 28, 2022 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Defective Component” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Defective Component1
  • Difficult to Remove1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1
  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 28, 2022Difficult to Remove; Difficult to Remove

    IT WAS REPORTED THAT REMOVAL DIFFICULTIES WERE ENCOUNTERED. THE PATIENT PRESENTED WITH PERIPHERAL ARTERY DISEASE. THE TARGET LESION WAS LOCATED IN THE LEFT SUPERFICIAL FEMORAL ARTERY. A 8X120X120 EPIC VASCULAR STENT WAS ADVANCED FOR TREATMENT AND WAS DEPLOYED. HOWEVER, THE DEPLOYMENT DEVICE GOT STUCK ON A NON-BOSTON SCIENTIFIC (BSC) GUIDEWIRE UPON REMOVAL OUT OF THE SHEATH. THE PHYSICIAN HAD TO WORK VERY HARD TO REMOVE THE DEPLOYMENT DEVICE OVER THE GUIDEWIRE. THE PROCEDURE WAS COMPLETED WITH THE INDICATED DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14846655 ↗
  • InjuryAug 6, 2018Defective Component; Defective Component

    IT WAS REPORTED THAT STENT ELONGATION OCCURRED. THE TARGET LESION WAS LOCATED IN THE EXTERNAL ILIAC ARTERY. A 8X120X120MM EPIC¿ VASCULAR STENT WAS IMPLANTED TO TREAT THE LESION. HOWEVER, IT WAS NOTED THAT THE STENT WAS ELONGATED DURING DEPLOYMENT APPROXIMATELY 160MM TO 170MM AND EXTENDED INTO THE AORTA. THE DEVICE WAS LEFT INSIDE THE PATIENT. THE PHYSICIAN THEN DECIDED TO ADVANCED, A 10X20MM MUSTANG BALLOON CATHETER TO PRESS THE STENT AGAINST THE WALL AND DRAGGED IT BACK DOWN INTO THE COMMON ILIAC ARTERY AND THE PROCEDURE WAS COMPLETED. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS WAS FINE.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 7753368 ↗

Other STENT, ILIAC devices

All STENT, ILIAC devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page